Ivan El-Sayed, MD

Brown University, Providence, Rhode Island, Sc. B, 1992, Neuroscience
Boston University Medical School, Boston, MA, M.D., 1992-1996, Medicine
Boston University Medical Ctr, Boston, MA, 1996-2001, Otolaryngology-HNS
University of California, San Francisco, Postdoctoral, 2002-2003, Head and Neck Oncology-Fellowship

• 1996-1997
  Intern, Boston University Medical Center, Worcester, MA
• 1997-2001
  Resident in Otolaryngology, Boston Univeristy Medical Center, Worcester, MA
• 2001-2002
  Staff Physician, Fallon Clinic Department of Otolaryngology
• 2002-2003
  Fellow, Department of Otolaryngology, University of California, San Francisco
• 2002-2003
  Clinical Instructor, Department of Otolaryngology, UCSF
• 2004-2009
  Assistant Professor, Department of Otolaryngology, UCSF
• 2009-present
  Associate Professor, Department of Otolaryngology, UCSF

• 1995
  Member, Alpha Omega Alpha Honor Society
• 1998
  First Place: Ethics of Cochlear Implantation in Young Children, New England Otolaryngology Society
• 2002
  U.S. Patent: Spectroscopic Diagnostics for Bacteria in Biologic Samples. Ivan El-Sayed, MD and Mostafa El-Sayed, PhD
• 2002-2012
  Board Certified by the American Board of Otolaryngology
• 2003
  THANKS Star Award, UCSF Medical Center
• 2005
  "Quality Award" UCSF Medical Center Quality Improvement Office. For: Altered Airway PI Project. Member of the committee which developed this form.
• 2007
  U.S. Patent: GTRC 3424 U.S.S.N. 11/913,915 "Shape Tunable Plasmonic Nanoparticles" Mostafa A. El-Sayed and Ivan Homer El-Sayed (Provisional Patent Filed 2005)
• 2007
  "Hot Paper", American Chemical Society Publications, first author. [As defined by the ACS: "Hot Papers are articles published within the last two years receiving the most citations over the most recent two-month period. In a typical two-month period, Essential Science Indicators recognizes more than 200 total Hot Papers in chemistry.] For Article: Surface Plasmon Resonance Scattering and Absorption of anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer Diagnostics: Applications in Oral Cancer. Nano Lett. 2005.
• 2007
  Outstanding Productive Physician and Surgeon, Certificate of Accomplishment, Department of Otolaryngology, UCSF
• 2007
  "Most Accessed Article" for the 3rd quarter of 2007, American Chemical Society Publications. For article: "Gold Nanorods for Nuclear Targeting. BioconjugChemistry 2007.
• 2008
  "Most Accessed Article" for first quarter 2008, American Chemical Society Publications: For article: Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine. J. Phys. Chem. B.; (Article); 2006
• 2008
  "Editor Selected Papers in Imaging"- Bioconjugate Chemistry- For Article: Peptide-Conjugated Gold Nanorods for Nuclear Targeting. Bioconjug Chem. 2007 Sep-Oct;18(5):1490-7. Epub 2007 Jul 13.
• 2008
  #1 ranked article in citations in the field of Chemistry for 2007. Described by ScienceWatch. For article: 14. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods. J Am Chem Soc. 2006 Feb 15;128(6):2115-2120.
• 2008
  "Hot Paper", American Chemical Society Publications. For article: Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods, J Am Chem Soc 2006.
• 2008
  "Most Cited Author"- First author- recognized as one of the top 20 cited papers in Cancer Letters toward the calculation of the 2007 impact factor. Cancer Letters. 2006 Jul 28;239(1):129-35.

• Fourier-transform Infrared Spectroscopic Comparison of Human Fibroblast and Fibrosarcoma Cells. Yang D, Castro DJ, El-Sayed IH, El-Sayed MA, Saxton RE, Zhang NY. SPIE Vol 2389, 1995, p542
• A Fourier-transform Infrared Spectroscopic Comparison of Cultured Human Fibroblast and Fibrosarcoma Cells: A New Method for Detection of Malignancies. Yang D, Castro DJ, El-Sayed IH, El-Sayed MA, Saxton RE, Zhang NY. Journal of Clinical Laser Medicine and Surgery, Vol 13, No 2 1995, pp55-59.
• Presentation and Treatment of Post-traumatic Pseudomeningocele of the Superior Orbit. Smith DK, Pafundi E, El-Sayed IH, Dolan RW. American Journal of Otolaryngology. Vol 21 No3 May 2000, p219-21.
• Otologic Manifestations of Amyloidosis. El-Sayed I, Busaba NY., Faquin WC. Otology and Neurotology 23(2):158-159, March 2002.
• El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005 May;5(5):829-34.
• Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Determination of the Minimum Temperature Required for Selective Photothermal Destruction of Cancer Cells Using Immunotargeted Gold Nanoparticles. Photochem Photobiol. 2006 Mar-Apr;82(2):412-7. ISI Impact Factor: 2.172
• Daly ME, Chen AM, Bucci MK, El-Sayed I, Xia P, Kaplan MJ, Eisele DW. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):151-7. Impact Factor: 4.290
• Huang X, Qian W, El-Sayed IH, El-Sayed MA. The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy. Lasers Surg Med. 2007 Oct;39(9):747-53.
• Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008 Jul;23(3):217-28. Epub ahead of print 2007 Aug 3. ISI Impact Factor: 1.186
• Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. Nano Lett. 2007 Jun;7(6):1591-7. Epub 2007 May 3. ISI Impact Factor: 9.627
• Oyelere AK, Chen PC, Huang X, El-Sayed IH, El-Sayed MA. Peptide-Conjugated Gold Nanorods for Nuclear Targeting. Bioconjug Chem. 2007 Sep-Oct;18(5):1490-7. Epub 2007 Jul 13. ISI Impact Factor: 4.384
• Saito DM, Glastonbury CM, El-Sayed IH, Eisele DW. Parapharyngeal space schwannomas: preoperative imaging determination of the nerve of origin. Arch Otolaryngol Head Neck Surg. 2007 Jul;133(7):662-7. ISI Impact Factor: 1.4
• Chen AM, Daly ME, El-Sayed I, Garcia J, Lee NY, Bucci MK, Kaplan MJ. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):338-43. Impact Factor: 4.290
• Chen AM, Daly ME, Bucci MK, Xia P, Akazawa C, Quivey JM, Weinberg V, Garcia J, Lee NY, Kaplan MJ, El-Sayed I, Eisele DW, Fu KK, Phillips TL. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):141-7. Epub 2007 Apr 24. Impact Factor: 4.290
• El-Sayed IH, Macharet F, Huang X, Humstoe JO, Kramer R, El-Sayed MA. Effect of plasmonic gold nanoparticles on benign and malignant cellular autofluorescence: A novel probe for fluorescence based detection of cancer. Technology in Cancer Treatment and Research. October 2007: 6(5):403-412.
• Antonia Kolokythas A, Eisele DW, El-Sayed I, Schmidt BL. Mandibular Osteotomies for Access to Parapharyngeal Space Neoplasms. Head and Neck. (Accepted June 2008) ISI Impact Factor 2.007
• EB Dickerson, EC Dreaden, X Huang, IH El-Sayed, H Chub S Pushpanketh, JF McDonald, MA El-Sayed. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. epub Cancer Letters May 2008. ISI Impact Factor: 3.398
• El-Sayed IH Roediger FC, Goldberg AN, Parsa AT, McDermott MW. Endoscopic Reconstruction of Skull Base Defects with the Nasal Septal Flap. Skull Base 2008; 18: 385-394. Impact Factor: 0.5
• Kolokythas A, Eisele DW, El-Sayed I, Schmidt BL. Mandibular osteotomies for access to select parapharyngeal space neoplasms. Head Neck. 2008 Oct 13. [Epub ahead of print]